About Emgality
Emgality is a company based in Indianapolis (United States) founded in 2016 was acquired by Royalty Pharma in April 2019. Emgality operates in a competitive market with competitors including Evergreen Nephrology, Pathalys, AdaptX, Specialty Networks and Bial, among others.
- Headquarter Indianapolis, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Royalty Pharma
(Apr 01, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Emgality
Detailed funding history for Emgality
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Emgality
Emgality has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Royalty Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made in marketed and late-stage biopharmaceutical companies.
|
Locked | Locked | Locked |
Investor details for Emgality
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Emgality
Investment portfolio details for Emgality
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Emgality
Detailed financials for Emgality
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Emgality Comparisons
Peer comparison for Emgality
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Emgality
Emgality operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Evergreen Nephrology, Pathalys, AdaptX, Specialty Networks and Bial, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Chronic care management services for kidney diseases are provided.
|
|
| Locked | Locked | Locked |
Biotherapeutics for chronic kidney disease are developed and provided.
|
|
| Locked | Locked | Locked |
Clinical management solutions are provided for healthcare by AdaptX.
|
|
| Locked | Locked | Locked |
Specialty Networks is focused on supporting independent specialty healthcare providers.
|
|
| Locked | Locked | Locked |
Develops and commercializes pharmaceutical products through research and global distribution.
|
|
| Locked | Locked | Locked |
Chronic care management services are provided to patients.
|
Detailed competitors of Emgality
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Emgality
Complete news archive for Emgality
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Emgality
Emgality was founded in 2016.
Emgality is headquartered in Indianapolis, United States. It is registered at Indianapolis, Indiana, United States.
Dave Ricks is the current CEO of Emgality.
Emgality was founded in 2016 and is headquartered in Indianapolis, United States. Patient healthcare services are offered within the broader healthcare sector, focusing on support for medical needs. Operations are managed through the domain emgality.com, with leadership provided by CEO Dave Ricks. Services emphasize patient assistance and care delivery in the United States, addressing various health requirements factually and efficiently.
Emgality's top competitors include Evergreen Nephrology, Pathalys and AdaptX.
Emgality has 1 investor. Key investors include Royalty Pharma.